======= DUS2 ======= == Gene Information == * **Official Symbol**: DUS2 * **Official Name**: dihydrouridine synthase 2 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=54920|54920]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q9NX74|Q9NX74]] * **Interactions**: [[https://thebiogrid.org/search.php?search=DUS2&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20DUS2|Open PubMed]] * **OMIM**: [[https://omim.org/entry/609707|Open OMIM]] == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: Dihydrouridine synthase. Catalyzes the synthesis of dihydrouridine, a modified base found in the D-loop of most tRNAs. Negatively regulates the activation of EIF2AK2/PKR. {ECO:0000269|PubMed:15994936, ECO:0000269|PubMed:18096616}. |Dus| |dsrm| |tRNA-dihydrouridine20 synthase activity| |tRNA dihydrouridine synthesis| |tRNA dihydrouridine synthase activity| |NADPH binding| |FMN binding| |protein kinase inhibitor activity| |flavin adenine dinucleotide binding| |double-stranded RNA binding| |tRNA modification| |tRNA processing| |RNA modification| |tRNA metabolic process| |negative regulation of protein kinase activity| |negative regulation of kinase activity| |negative regulation of transferase activity| |ncRNA processing| |negative regulation of protein phosphorylation| |negative regulation of phosphorylation| |ncRNA metabolic process| |negative regulation of phosphate metabolic process| |negative regulation of phosphorus metabolic process| |negative regulation of protein modification process| |negative regulation of catalytic activity| |regulation of protein kinase activity| |regulation of kinase activity| |RNA processing| |oxidation-reduction process| |regulation of transferase activity| |negative regulation of cell death| |endoplasmic reticulum| |negative regulation of cellular protein metabolic process| |negative regulation of protein metabolic process| |negative regulation of molecular function| |regulation of protein phosphorylation| |regulation of phosphorylation| |RNA metabolic process| |regulation of cell death| |regulation of phosphate metabolic process| |regulation of phosphorus metabolic process| |regulation of protein modification process| |gene expression| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp334|All-trans-Retinoic-Acid 40μM R07 exp334]]|-2.1| |[[:results:exp319|ABT-702 5μM plus Dimethyloxaloylglycine 11μM R07 exp319]]|-2| |[[:results:exp413|THZ531 0.11 to 0.175μM on day4 R07 exp413]]|-1.92| |[[:results:exp311|2-Methoxyestradiol 0.55 to 0.75μM on day4 R07 exp311]]|-1.82| |[[:results:exp359|FK-506 30μM R07 exp359]]|-1.78| |[[:results:exp216|Erlotinib 10μM R05 exp216]]|-1.73| |[[:results:exp389|PF-06409577 20μM R07 exp389]]|-1.72| No correlation found to any other genes in chemogenomics. Global Fraction of Cell Lines Where Essential: 0/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 6816 * **Expression level (log2 read counts)**: 4.51 {{:chemogenomics:nalm6 dist.png?nolink |}}